Search for: "Berry v. Bristol-Myers Squibb Company et al" Results 1 - 3 of 3
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
IP Think Tank Global Week in Review - 25 April 2008
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
The Doubling Dose
5 Jun 2013, 5:29 am by Schachtman
Bristol-Myers Squibb, 97 F. [read post]
Tortini - http://schachtmanlaw.com/blog/
Reference Manual on Scientific Evidence on Relative Risk Greater Than Two For Specific Causation Inference
25 Apr 2015, 11:03 am by Schachtman
., citing Ofer Shpilberg, et al., The Next Stage: Molecular Epidemiology, 50 J. [read post]
Tortini - http://schachtmanlaw.com/blog/